Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Hydralazine tablets		Hydroxyzine (Atarax, Ucerax): risk of QT interval prolongation and Torsade de Pointes
Hydrocortisone 0.1% lipocream		Potent
Hydrocortisone 0.5% cream	TA81 - Frequency of application of topical corticosteroids for atopic eczema	Mild potency
Hydrocortisone 0.5% ointment	TA81 - Frequency of application of topical corticosteroids for atopic eczema	Mild potency
Hydrocortisone 1% and Oxytetracycline 3% (Terra-Cortril®) ointment		Potency: mild
Hydrocortisone 1% cream	TA81 - Frequency of application of topical corticosteroids for atopic eczema	Mild potency
Hydrocortisone 1% ointment	TA81 - Frequency of application of topical corticosteroids for atopic eczema	Mild potency
Hydrocortisone acetate injection
Hydrocortisone butyrate 0.1% cream		Potent
Hydrocortisone butyrate 0.1% ointment		Potent

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.